Literature DB >> 24623012

Evaluation of the necessity of primary tumor resection for synchronous metastatic colorectal cancer.

Yuji Miyamoto1, Masayuki Watanabe, Yasuo Sakamoto, Hironobu Shigaki, Asuka Murata, Hidetaka Sugihara, Kojiro Etoh, Takatsugu Ishimoto, Masaaki Iwatsuki, Yoshifumi Baba, Shiro Iwagami, Naoya Yoshida, Hideo Baba.   

Abstract

PURPOSE: We evaluated the need for primary tumor resection in patients with colorectal cancer (CRC) and synchronous unresectable metastases who underwent chemotherapy, and identified the associations between the primary tumor characteristics and risk of intestinal obstruction or perforation.
METHODS: We retrospectively analyzed the survival and complication rates of patients with synchronous metastatic CRC treated between April 2005 and December 2011.
RESULTS: Of 131 patients, 68 underwent primary tumor resection before chemotherapy, and 63 were treated without resection before chemotherapy. The overall survival (OS) did not significantly differ between the two groups (log-rank P = 0.53). In the resection group, 12 patients (17.6%) developed postoperative complications. In the non-resection group, 16 patients (25.4%) required surgical intervention owing to obstruction or perforation during their treatment. Surgical intervention did not affect the OS. A circumferential tumor was a risk factor for obstruction or perforation of the colorectum in non-resected patients (odds ratio = 11.163; P = 0.006).
CONCLUSION: Resection of primary tumors before chemotherapy is unnecessary in selected patients with synchronous metastatic colorectal cancer. A circumferential tumor is a risk factor for obstruction or perforation during chemotherapy in cases without primary tumor resection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24623012     DOI: 10.1007/s00595-014-0869-5

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  25 in total

1.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer.

Authors:  Toshiaki Watanabe; Michio Itabashi; Yasuhiro Shimada; Shinji Tanaka; Yoshinori Ito; Yoichi Ajioka; Tetsuya Hamaguchi; Ichinosuke Hyodo; Masahiro Igarashi; Hideyuki Ishida; Megumi Ishiguro; Yukihide Kanemitsu; Norihiro Kokudo; Kei Muro; Atsushi Ochiai; Masahiko Oguchi; Yasuo Ohkura; Yutaka Saito; Yoshiharu Sakai; Hideki Ueno; Takayuki Yoshino; Takahiro Fujimori; Nobuo Koinuma; Takayuki Morita; Genichi Nishimura; Yuh Sakata; Keiichi Takahashi; Hiroya Takiuchi; Osamu Tsuruta; Toshiharu Yamaguchi; Masahiro Yoshida; Naohiko Yamaguchi; Kenjiro Kotake; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2011-10-15       Impact factor: 3.402

2.  Impact of second-line and later cetuximab-containing therapy and KRAS genotypes in patients with metastatic colorectal cancer: a multicenter study in Japan.

Authors:  Hiroshi Saeki; Yasunori Emi; Ryuichi Kumashiro; Hajime Otsu; Hiroyuki Kawano; Koji Ando; Satoshi Ida; Yasue Kimura; Eriko Tokunaga; Eiji Oki; Masaru Morita; Mototsugu Shimokawa; Yoshihiko Maehara
Journal:  Surg Today       Date:  2013-09-08       Impact factor: 2.549

3.  Prognosis of carcinoma of the large bowel in the presence of liver metastases.

Authors:  E M Oxley; H Ellis
Journal:  Br J Surg       Date:  1969-02       Impact factor: 6.939

4.  Elective palliative resection of incurable stage IV colorectal cancer: who really benefits from it?

Authors:  Renato Costi; Davide Di Mauro; Licia Veronesi; Andrea Ardizzoni; Pierfranco Salcuni; Luigi Roncoroni; Leopoldo Sarli; Vincenzo Violi
Journal:  Surg Today       Date:  2011-01-26       Impact factor: 2.549

5.  Non-operative management of the primary tumour in patients with incurable stage IV colorectal cancer.

Authors:  A I Sarela; J A Guthrie; M T Seymour; E Ride; P J Guillou; D S O'Riordain
Journal:  Br J Surg       Date:  2001-10       Impact factor: 6.939

Review 6.  Comparison of colonic stenting and open surgery for malignant large bowel obstruction.

Authors:  H S Tilney; R E Lovegrove; S Purkayastha; P S Sains; G K Weston-Petrides; A W Darzi; P P Tekkis; A G Heriot
Journal:  Surg Endosc       Date:  2006-12-09       Impact factor: 4.584

7.  Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

Authors:  Leonard B Saltz; Stephen Clarke; Eduardo Díaz-Rubio; Werner Scheithauer; Arie Figer; Ralph Wong; Sheryl Koski; Mikhail Lichinitser; Tsai-Shen Yang; Fernando Rivera; Felix Couture; Florin Sirzén; Jim Cassidy
Journal:  J Clin Oncol       Date:  2008-04-20       Impact factor: 44.544

8.  Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601.

Authors:  F Ferrand; D Malka; A Bourredjem; C Allonier; O Bouché; S Louafi; V Boige; M Mousseau; J L Raoul; L Bedenne; B Leduc; P Deguiral; M Faron; J P Pignon; M Ducreux
Journal:  Eur J Cancer       Date:  2012-08-25       Impact factor: 9.162

9.  Stents for palliation of obstructive metastatic colon cancer: impact on management and chemotherapy administration.

Authors:  Mehdi Karoui; Antoine Charachon; Catherine Delbaldo; Jérome Loriau; Alexis Laurent; Iradj Sobhani; Jeanne Tran Van Nhieu; Jean Charles Delchier; Pierre-Louis Fagniez; Pascal Piedbois; Daniel Cherqui
Journal:  Arch Surg       Date:  2007-07

10.  Prognostic value of resection of primary tumor in patients with stage IV colorectal cancer: retrospective analysis of two randomized studies and a review of the literature.

Authors:  Sabine Venderbosch; Johannes H de Wilt; Steven Teerenstra; Olaf J Loosveld; Aart van Bochove; Harm A Sinnige; Geert-Jan M Creemers; Margot E Tesselaar; Linda Mol; Cornelis J A Punt; Miriam Koopman
Journal:  Ann Surg Oncol       Date:  2011-08-06       Impact factor: 5.344

View more
  7 in total

1.  Feasibility of the liver-first approach for patients with initially unresectable and not optimally resectable synchronous colorectal liver metastases.

Authors:  Masayuki Okuno; Etsuro Hatano; Yosuke Kasai; Takahiro Nishio; Satoru Seo; Kojiro Taura; Kentaro Yasuchika; Takashi Nitta; Akira Mori; Hideaki Okajima; Toshimi Kaido; Suguru Hasegawa; Shigemi Matsumoto; Yoshiharu Sakai; Shinji Uemoto
Journal:  Surg Today       Date:  2015-08-28       Impact factor: 2.549

2.  Prognoses and treatment strategies for synchronous peritoneal dissemination of colorectal carcinoma.

Authors:  Harunobu Sato; Kunihiro Toyama; Yoshikazu Koide; Shinji Ozeki; Kouhei Hatta; Kotaro Maeda
Journal:  Surg Today       Date:  2015-10-03       Impact factor: 2.549

3.  Complications from the primary tumour are not related with survival in patients with synchronous stage IV colorectal cancer receiving chemotherapy without primary tumour resection.

Authors:  Javier Suárez; Gabriel Marín; Ruth Vera; Begoña Oronoz; Fabiola Oteiza; Elena Mata
Journal:  Int J Colorectal Dis       Date:  2015-07-07       Impact factor: 2.571

4.  Primary Tumor Resection in Patients with Incurable Localized or Metastatic Colorectal Cancer: A Systematic Review and Meta-analysis.

Authors:  Constantinos Simillis; Eliana Kalakouti; Thalia Afxentiou; Christos Kontovounisios; Jason J Smith; David Cunningham; Michel Adamina; Paris P Tekkis
Journal:  World J Surg       Date:  2019-07       Impact factor: 3.352

5.  Primary Tumor-Related Complications and Salvage Outcomes in Patients with Metastatic Rectal Cancer and an Untreated Primary Tumor.

Authors:  Winson J Tan; Sujata Patil; Jose G Guillem; Philip B Paty; Martin R Weiser; Garrett M Nash; J Joshua Smith; Emmanouil P Pappou; Iris H Wei; Julio Garcia-Aguilar
Journal:  Dis Colon Rectum       Date:  2021-01       Impact factor: 4.412

6.  Asymptomatic primary tumour in incurable metastatic colorectal cancer: is there a role for surgical resection prior to systematic therapy or not?

Authors:  Narimantas E Samalavicius; Audrius Dulskas; Edita Baltruskeviciene; Giedre Smailyte; Marija Skuciene; Rasa Mikelenaite; Rasa Venslovaite; Eduardas Aleknavicius; Almantas Samalavicius; Raimundas Lunevicius
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2016-12-31       Impact factor: 1.195

7.  Meta-analysis of oncologic effect of primary tumor resection in patients with unresectable stage IV colorectal cancer in the era of modern systemic chemotherapy.

Authors:  Gi Won Ha; Jong Hun Kim; Min Ro Lee
Journal:  Ann Surg Treat Res       Date:  2017-07-30       Impact factor: 1.859

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.